Antiretroviral therapy containing an integrase strand transfer inhibitor (INSTI) plus two NRTIs
has become the recommended treatment for antiretroviral-naive HIV-1-infected patients in …

Although human immunodeficiency virus type 1 (HIV-1) infection causes serious health
problems in Indonesia, information in regard to drug resistance is limited. We performed a …

Background: This study aims to delineate the resistance profiles to integrase strand transfer
inhibitors (INSTIs) among patients in southern Taiwan who have experienced antiretroviral …

Background With the widespread use of integrase strand transfer inhibitors (INSTIs) in the
clinical setting, transmission of INSTIs-resistance mutations may increase. Data regarding …

Background Little is known about the extent and predictors of polymorphisms potentially
influencing the susceptibility to HIV integrase inhibitors (INIs). Methods Genetic sequences …

Objectives To define whether the prevalence of mutations associated with integrase inhibitor
(INI) resistance is different in untreated versus antiretroviral-treated HIV-1-infected …

Objectives The aim of this study was to characterize the prevalence and patterns of
genotypic integrase inhibitor (INI) resistance in relation to HIV-1 clade. Methods The cohort …

There are limited real-world mutational and virological outcomes data of
treatmentexperienced persons diagnosed with HIV-1 subtype C (HIV-1 C) who are failing …

Updated guidelines for the treatment of antiretroviral therapy (ART)-negative patients with
HIV recommend integrase strand transfer inhibitor (INSTI)-based regimens. HIV patients are …

Background HIV treatment guidelines have traditionally recommended that all HIV-positive
individuals are tested for evidence of drug resistance prior to starting ART. Testing for …